Cargando…
Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
Radioresistance is one of the main determinants of treatment outcome in oral squamous cell carcinoma (OSCC), but its prediction is difficult. Several authors aimed to establish radioresistant OSCC cell lines to identify genes with altered expression in response to radioresistance. The development of...
Autores principales: | Nayak, Seema, Bhatt, M. L. B., Goel, Madhu Mati, Gupta, Seema, Mahdi, Abbas Ali, Mishra, Anupam, Mehrotra, Divya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023195/ https://www.ncbi.nlm.nih.gov/pubmed/29953521 http://dx.doi.org/10.1371/journal.pone.0199665 |
Ejemplares similares
-
Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018) -
Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma
por: Nayak, Seema, et al.
Publicado: (2015) -
Phosphatase and Tensin Homolog Immunohistochemical Expression and Promoter Methylation Status in Endometrioid Endometrial Carcinoma and Its Precursor Lesions
por: Yadav, Sunita, et al.
Publicado: (2022) -
Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma
por: Mishra, Sridhar, et al.
Publicado: (2020) -
Methylation of TGM-3 Promoter and Its Association with Oral Squamous Cell Carcinoma (OSCC)
por: Shojaeian, Sorour, et al.
Publicado: (2021)